The global injectable drug delivery technology market will grow from $22.5 billion last year to $43.3 billion by 2017, with conventional injection systems accounting for the biggest market share, according to a Markets and Markets report. Expedited growth is being driven by factors such as technological advances and the growing incidence of diabetes and cancer.

Related Summaries